JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB287109

ML-385

Be the first to review this product! Submit a review

|

(2 Publications)

MW 511.6 Da, Purity >98%. A potent and selective Nrf2 inhibitor (Nrf2; IC50 = 1.9 μM). ML-385 blocks Nrf2 downstream target gene expression. ML-385 displays specificity and selectivity for NSCLC cells with KEAP1 mutation, which leads to gain of Nrf2 function.

Key facts

CAS number

846557-71-9

Purity

>98%

Form

Solid

form

Molecular weight

511.6 Da

Molecular formula

C<sub>2</sub><sub>9</sub>H<sub>2</sub><sub>5</sub>N<sub>3</sub>O<sub>4</sub>S

PubChem

1383822

Nature

Synthetic

Solubility

>25 mg/ml in DMSO

Biochemical name

2-(1,3-benzodioxol-5-yl)-N-[5-methyl-4-[1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide

Biological description

A potent and selective Nrf2 inhibitor (Nrf2; IC50 = 1.9 μM). ML-385 blocks Nrf2 downstream target gene expression. ML-385 displays specificity and selectivity for NSCLC cells with KEAP1 mutation, which leads to gain of Nrf2 function.

Canonical smiles

CC1=CC=CC=C1C(=O)N2CCC3=C2C=CC(=C3)C4=C(SC(=N4)NC(=O)CC5=CC6=C(C=C5)OCO6)C

InChi

InChI=1S/C29H25N3O4S/c1-17-5-3-4-6-22(17)28(34)32-12-11-20-15-21(8-9-23(20)32)27-18(2)37-29(31-27)30-26(33)14-19-7-10-24-25(13-19)36-16-35-24/h3-10,13,15H,11-12,14,16H2,1-2H3,(H,30,31,33)

InChiKey

LINHYWKZVCNAMQ-UHFFFAOYSA-N

IUPAC Name

2-(1,3-benzodioxol-5-yl)-N-[5-methyl-4-[1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl]-1,3-thiazol-2-yl]acetamide

Product details

This product is manufactured by BioVision, an Abcam company and was previously called B2605 ML-385. B2605-25 is the same size as the 25 mg size of ab287109.

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
It is important to note that this product is reported to be light sensitive|Store in the dark

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Renal failure 45:2165103 PubMed36938748

2023

Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chenlei Lv,Tianyang Cheng,Bingbing Zhang,Ke Sun,Keda Lu

ACS chemical biology 11:3214-3225 PubMed27552339

2016

Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Anju Singh,Sreedhar Venkannagari,Kyu H Oh,Ya-Qin Zhang,Jason M Rohde,Li Liu,Sridhar Nimmagadda,Kuladeep Sudini,Kyle R Brimacombe,Sachin Gajghate,Jinfang Ma,Amy Wang,Xin Xu,Sampada A Shahane,Menghang Xia,Juhyung Woo,George A Mensah,Zhibin Wang,Marc Ferrer,Edward Gabrielson,Zhuyin Li,Fraydoon Rastinejad,Min Shen,Matthew B Boxer,Shyam Biswal
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com